Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.9M Buy
301,563
+6,165
+2% +$1.94M 0.14% 131
2026
Q1
$97.1M Buy
295,398
+8,450
+3% +$3.03M 0.16% 118
2025
Q4
$101M Buy
286,948
+14,819
+5% +$5.4M 0.17% 115
2025
Q3
$101M Buy
272,129
+16,260
+6% +$6.28M 0.18% 109
2025
Q2
$101M Buy
255,869
+15,369
+6% +$5.75M 0.21% 105
2025
Q1
$89.5M Buy
240,500
+33,168
+16% +$12.6M 0.22% 100
2024
Q4
$74.6M Buy
207,332
+79,223
+62% +$29.4M 0.19% 106
2024
Q3
$46.3M Buy
128,109
+4,086
+3% +$1.41M 0.12% 201
2024
Q2
$42.2M Buy
124,023
+14,800
+14% +$5.01M 0.12% 199
2024
Q1
$39.1M Buy
109,223
+2,875
+3% +$967K 0.13% 193
2023
Q4
$31.8M Buy
106,348
+10,734
+11% +$3.01M 0.11% 211
2023
Q3
$26.1M Sell
95,614
-3,763
-4% -$1.08M 0.11% 230
2023
Q2
$30.3M Buy
99,377
+26,254
+36% +$7.58M 0.12% 196
2023
Q1
$20.9M Sell
73,123
-56,018
-43% -$14.9M 0.09% 322
2022
Q4
$31.6M Buy
129,141
+45,396
+54% +$10.3M 0.16% 156
2022
Q3
$17M Sell
83,745
-12,348
-13% -$2.6M 0.1% 292
2022
Q2
$19.1M Buy
96,093
+8,998
+10% +$2.11M 0.1% 271
2022
Q1
$23.3M Sell
87,095
-21,254
-20% -$5.5M 0.12% 197
2021
Q4
$29M Buy
108,349
+1,662
+2% +$436K 0.12% 167
2021
Q3
$28.1M Sell
106,687
-5,364
-5% -$1.43M 0.13% 168
2021
Q2
$29.1M Sell
112,051
-3,457
-3% -$884K 0.13% 168
2021
Q1
$28.1M Buy
115,508
+604
+0.5% +$145K 0.14% 152
2020
Q4
$28.2M Buy
114,904
+3,032
+3% +$687K 0.15% 139
2020
Q3
$23.3M Sell
111,872
-3,614
-3% -$702K 0.14% 132
2020
Q2
$20.8M Sell
115,486
-5,105
-4% -$942K 0.13% 137
2020
Q1
$20.1M Buy
120,591
+49
+0% +$9.57K 0.15% 129
2019
Q4
$25.3M Sell
120,542
-517
-0.4% -$107K 0.15% 131
2019
Q3
$26.2M Sell
121,059
-5,088
-4% -$1.09M 0.18% 118
2019
Q2
$25.9M Sell
126,147
-3,107
-2% -$593K 0.18% 118
2019
Q1
$25.5M Buy
129,254
+187
+0.1% +$33.7K 0.17% 128
2018
Q4
$20.2M Sell
129,067
-36,684
-22% -$6.14M 0.15% 145
2018
Q3
$29.5M Sell
165,751
-6,171
-4% -$1.05M 0.16% 139
2018
Q2
$29M Sell
171,922
-1,023
-0.6% -$172K 0.17% 135
2018
Q1
$27.8M Sell
172,945
-16,710
-9% -$2.69M 0.17% 133
2017
Q4
$29.4M Sell
189,655
-24,643
-11% -$3.76M 0.17% 140
2017
Q3
$30.4M Buy
214,298
+5,250
+3% +$753K 0.16% 148
2017
Q2
$29M Buy
209,048
+5,330
+3% +$731K 0.16% 150
2017
Q1
$26.8M Sell
203,718
-42,557
-17% -$5.38M 0.15% 152
2016
Q4
$29.5M Buy
246,275
+42,537
+21% +$4.89M 0.18% 133
2016
Q3
$23.7M Buy
203,738
+3,192
+2% +$372K 0.15% 155
2016
Q2
$24M Buy
200,546
+24,190
+14% +$2.7M 0.16% 141
2016
Q1
$18.9M Buy
176,356
+2,400
+1% +$237K 0.14% 157
2015
Q4
$16.2M Sell
173,956
-2,306
-1% -$221K 0.12% 180
2015
Q3
$16.6M Sell
176,262
-3,605
-2% -$357K 0.14% 171
2015
Q2
$17.2M Buy
179,867
+27,920
+18% +$2.65M 0.12% 195
2015
Q1
$14M Buy
151,947
+35,993
+31% +$3.35M 0.1% 244
2014
Q4
$10.9M Sell
115,954
-330
-0.3% -$29.3K 0.08% 265
2014
Q3
$9.39M Sell
116,284
-50
-0% -$4.11K 0.07% 292
2014
Q2
$9.81M Sell
116,334
-940
-0.8% -$76.8K 0.08% 299
2014
Q1
$9.55M Buy
117,274
+5,310
+5% +$422K 0.08% 285
2013
Q4
$8.41M Buy
111,964
+36,451
+48% +$2.66M 0.07% 307
2013
Q3
$5.1M Sell
75,513
-29,144
-28% -$2.01M 0.04% 403
2013
Q2
$6.77M Buy
+104,657
New +$6.95M 0.07% 293

Other funds holding SYK

Aviva's SYK Position: Q2 2026 in Review

Aviva increased its Stryker (SYK) stake by 2.1% in Q2 2026, buying an estimated $1.94M and bringing the position to 301,563 shares worth $94.9M. The position accounts for 0.14% of the portfolio, ranked #131.

Aviva first reported a position in SYK in Q2 2013 and has held it in 53 quarters since. The position peaked at $101M in Q2 2025. 2,244 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Aviva held 301,563 shares of Stryker worth $94.9M as of Q2 2026.
  • Aviva bought 6,165 Stryker shares in Q2 2026, an estimated $1.94M.
  • Stryker made up 0.14% of Aviva's portfolio in Q2 2026, its #131 holding.
  • Aviva first reported a position in Stryker in Q2 2013 and has held it in 53 quarters since.
  • Aviva's Stryker position peaked at $101M in Q2 2025.
  • 2,244 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.